dopamine reuptake inhibitor < dopamine transporter < dopamine transporter SPECT

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000121 (2011)	Michael A. Schwarzschild [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Danna Jennings [États-Unis] ; John Seibyl [États-Unis] ; Alberto Ascherio [États-Unis]	Serum urate and probability of dopaminergic deficit in early “Parkinson's disease”
000132 (2011)	Kelvin L. Chou [États-Unis] ; Robert A. Koeppe [États-Unis] ; Nicolaas I. Bohnen [États-Unis]	Rhinorrhea: A common nondopaminergic feature of Parkinson's disease
000F47 (2009)	Christoph Scherfler [Autriche] ; Michael Nocker [Autriche]	Dopamine transporter SPECT: How to remove subjectivity?
001092 (2008)	Michele Tinazzi [Italie] ; Sarah Ottaviani [Italie] ; Ioannis U. Isaias [Italie] ; Isabella Pasquin [Italie] ; Maria Steinmayr [Italie] ; Claudio Vampini [Italie] ; Manuela Pilleri [Italie] ; Giuseppe Moretto [Italie] ; Antonio Fiaschi [Italie] ; Nicola Smania [Italie] ; Piergiorgio Giorgetti [Italie] ; Angelo Antonini [Italie]	[123I]FP‐CIT SPET imaging in drug‐induced Parkinsonism
001237 (2008)	Roberto Ceravolo [Italie] ; Angelo Antonini [Italie] ; Duccio Volterrani [Italie] ; Carlo Rossi [Italie] ; Lorenzo Kiferle [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie]	Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study
001288 (2008)	Gabor G. Kovacs [Autriche] ; Ivan J. Milenkovic [Autriche] ; Matthias Preusser [Autriche] ; Herbert Budka [Autriche]	Nigral burden of α‐synuclein correlates with striatal dopamine deficit
001703 (2007)	Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche]	Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
001736 (2007)	Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis]	Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease
001923 (2007)	Ming Chi Shih [Brésil] ; Luiz Augusto Franco De Andrade [Brésil] ; Edson Amaro Jr [Brésil] ; Andre Carvalho Felicio [Brésil] ; Henrique Ballalai Ferraz [Brésil] ; Jairo Wagner [Brésil] ; Marcelo Queiroz Hoexter [Brésil] ; Li Fu Lin [République populaire de Chine] ; Ying Kai Fu [République populaire de Chine] ; Jair Jesus Mari [Brésil] ; Sergio Tufik [Brésil] ; Rodrigo Affonseca Bressan [Brésil]	Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?—A [99mTc]‐TRODAT‐1 SPECT study
001C25 (2006)	Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]	Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP‐CIT SPECT
001D59 (2006)	Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada]	Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies
002358 (2005)	Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]	Dopaminergic innervation of the human striatum in Parkinson's disease
002672 (2004)	Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne]	Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes
002839 (2003)	Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]	Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
002882 (2003)	Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]	Role of dopamine transporter imaging in routine clinical practice
002883 (2003)	Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]	Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
002A49 (2003)	Paola P. Piccini [Royaume-Uni]	Dopamine transporter: Basic aspects and neuroimaging
002A74 (2003)	Walter Pirker [Autriche]	Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
002D89 (2002)	Y. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; C. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud]	Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean?
002E24 (2002)	Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]	Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
002E61 (2002)	Masataka Nishimura [Japon] ; Ryuji Kaji [Japon] ; Mitsuhiro Ohta [Japon] ; Ikuko Mizuta [Japon] ; Sadako Kuno [Japon]	Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i -k "dopamine transporter" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i  \
                -Sk "dopamine transporter" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    dopamine transporter
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024